首页> 美国卫生研究院文献>World Journal of Gastroenterology >Gender differences in hepatic ischemic reperfusion injury in rats are associated with endothelial cell nitric oxide synthase-derived nitric oxide
【2h】

Gender differences in hepatic ischemic reperfusion injury in rats are associated with endothelial cell nitric oxide synthase-derived nitric oxide

机译:大鼠肝缺血再灌注损伤的性别差异与内皮细胞一氧化氮合酶衍生的一氧化氮有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: This study was designed to examine the hypothesis that gender differences in I/R injury are associated with endothelial cell nitric oxide synthase (eNOS)-derived nitric oxide (NO).METHODS: Wistar rats were randomized into seven experimental groups (12 animals per group). Except for the sham operated groups, all rats were subjected to total liver ischemia for 40 min followed by reperfusion. All experimental groups received different treatments 45 min before the laparotomy. For each group, half of the animals (six) were used to investigate the survival; blood samples and liver tissues were obtained in the remaining six animals after 3 h of reperfusion to assess serum NO, alanine aminotransferase (ALT) and TNF-α levels, liver tissue malondialdehyde (MDA) content, and severity of hepatic I/R injury.RESULTS: Basal serum NO levels in female sham operated (FS) group were nearly 1.5-fold of male sham operated (MS) group (66.7±11.0 μmol/L vs 45.3±10.1 μmol/L, P<0.01). Although serum NO levels decreased significantly after hepatic I/R (P<0.01, vs sham operated groups), they were still significantly higher in female rat (F) group than in male rat (M) group (47.8±8.6 μmol/L vs 23.8±4.7 μmol/L, P<0.01). Serum ALT and TNF-α levels, and liver tissue MDA content were significantly lower in F group than in M group (370.5±46.4 U/L, 0.99±0.11 μg/L and 0.57±0.10 μmol/g vs 668.7±78.7 U/L, 1.71±0.18 μg/L and 0.86±0.11 μmol/g, respectively, P<0.01). I/R induced significant injury to the liver both in M and F groups (P<0.01 vs sham operated groups). But the degree of hepatocyte injury was significantly milder in F group than in M group (P<0.05 and P<0.01). The median survival time was six days in F group and one day in M group. The overall survival rate was significantly higher in F group than in M group (P<0.05). When compared with male rats pretreated with saline (M group), pretreatment of male rats with 17-β-estradiol (E2) (M+E2 group) significantly increased serum NO levels and significantly decreased serum ALT and TNF-α levels, and liver tissue MDA content after I/R (P<0.01). The degree of hepatocyte injury was significantly decreased and the overall survival rate was significantly improved in M+E2 group than in M group (P<0.01 and P<0.05). The NOS inhibitor Nw-nitro-L-arginine methyl ester (L-NAME) treatment could completely abolish the protective effects of estrogen in both male and female rats.CONCLUSION: The protective effects afforded to female rats subjected to hepatic I/R are associated with eNOS-derived NO.
机译:目的:本研究旨在检查以下假设:I / R损伤中的性别差异与内皮细胞一氧化氮合酶(eNOS)衍生的一氧化氮(NO)有关。方法:Wistar大鼠随机分为七个实验组(12只动物)每组)。除假手术组外,所有大鼠均进行全肝缺血40分钟,然后再灌注。所有实验组在剖腹手术前45分钟接受不同的治疗。对于每组,一半的动物(六只)用于研究存活率。再灌注3小时后,在其余六只动物中获取血液样本和肝组织,以评估血清NO,丙氨酸氨基转移酶(ALT)和TNF-α水平,肝组织丙二醛(MDA)含量以及肝I / R损伤的严重程度。结果:假手术组(FS)的基础血清NO水平约为假手术组(MS)的1.5倍(66.7±11.0μmol/ L vs 45.3±10.1μmol/ L,P <0.01)。尽管肝I / R后血清NO水平显着降低(P <0.01,与假手术组相比),但雌性大鼠(F)组仍显着高于雄性大鼠(M)组(47.8±8.6μmol/ L vs. 23.8±4.7μmol/ L,P <0.01)。 F组的血清ALT和TNF-α水平以及肝组织MDA含量显着低于M组(370.5±46.4 U / L,0.99±0.11μg/ L和0.57±0.10μmol/ g vs 668.7±78.7 U / L,分别为1.71±0.18μg/ L和0.86±0.11μmol/ g,P <0.01)。在M和F组中,I / R均对肝脏造成了明显的损伤(与假手术组相比,P <0.01)。但F组肝细胞损伤程度明显低于M组(P <0.05和P <0.01)。 F组中位生存时间为6天,M组中位生存时间为1天。 F组总生存率明显高于M组(P <0.05)。与用盐水预处理的雄性大鼠(M组)相比,用17-β-雌二醇(E2)预处理的雄性大鼠(M + E2组)显着增加血清NO水平,并显着降低血清ALT和TNF-α水平以及肝脏I / R后组织MDA含量(P <0.01)。与M组相比,M + E2组肝细胞损伤程度明显降低,总生存率明显提高(P <0.01和P <0.05)。结论:NOS抑制剂 N w -硝基-L-精氨酸甲酯(L-NAME)治疗可以完全消除雌激素对雌性和雌性大鼠的保护作用。对雌性大鼠进行肝脏I / R的保护作用与eNOS衍生的NO有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号